AR086483A2 - Vector de expresion, celula huesped, metodo para preparar un polipeptido antigenico, metodo y equipo para la deteccion de un polinucleotido, anticuerpo, metodo de empleo del anticuerpo, y uso para la manufactura de un medicamento para modular la fisiologia o el desarrollo de una celula o celulas de cultivo de tejido - Google Patents

Vector de expresion, celula huesped, metodo para preparar un polipeptido antigenico, metodo y equipo para la deteccion de un polinucleotido, anticuerpo, metodo de empleo del anticuerpo, y uso para la manufactura de un medicamento para modular la fisiologia o el desarrollo de una celula o celulas de cultivo de tejido

Info

Publication number
AR086483A2
AR086483A2 ARP120101391A ARP120101391A AR086483A2 AR 086483 A2 AR086483 A2 AR 086483A2 AR P120101391 A ARP120101391 A AR P120101391A AR P120101391 A ARP120101391 A AR P120101391A AR 086483 A2 AR086483 A2 AR 086483A2
Authority
AR
Argentina
Prior art keywords
antibody
detection
manufacture
expression vector
equipment
Prior art date
Application number
ARP120101391A
Other languages
English (en)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25413278&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR086483(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of AR086483A2 publication Critical patent/AR086483A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Un vector de expresión que comprende un polinucleótido que codifica: a) por lo menos 17 aminoácidos contiguos de la porción codificadora madura de la SEC ID Nº 2; b) por lo menos 17 aminoácidos contiguos de la porción codificadora madura de la SEC ID Nº 4; o c) por lo menos 17 aminoácidos contiguos de la porción codificadora madura de la SEC ID Nº 5. También se dan a conocer una célula huésped, método para preparar un polipéptido antigénico, método y equipo para la detección de un polinucleótido, anticuerpo, método de empleo del anticuerpo, y uso para la manufactura de un medicamento para modular la fisiología o el desarrollo de una célula o células de cultivo de tejido.
ARP120101391A 1997-07-25 2012-04-23 Vector de expresion, celula huesped, metodo para preparar un polipeptido antigenico, metodo y equipo para la deteccion de un polinucleotido, anticuerpo, metodo de empleo del anticuerpo, y uso para la manufactura de un medicamento para modular la fisiologia o el desarrollo de una celula o celulas de cultivo de tejido AR086483A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US90090597A 1997-07-25 1997-07-25

Publications (1)

Publication Number Publication Date
AR086483A2 true AR086483A2 (es) 2013-12-18

Family

ID=25413278

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP980103664A AR017510A1 (es) 1997-07-25 1998-07-24 Polinucleotido aislado o recombinante, vector de expresion, celula huesped, metodo para preparar un polipeptido antigenico, metodo y equipo para ladeteccion de un polinucleotido, compuesto de union, metodo de empleo del compuesto de union, polipeptido antigenico aislado o substancialmente puro, ymet
ARP120101391A AR086483A2 (es) 1997-07-25 2012-04-23 Vector de expresion, celula huesped, metodo para preparar un polipeptido antigenico, metodo y equipo para la deteccion de un polinucleotido, anticuerpo, metodo de empleo del anticuerpo, y uso para la manufactura de un medicamento para modular la fisiologia o el desarrollo de una celula o celulas de cultivo de tejido

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP980103664A AR017510A1 (es) 1997-07-25 1998-07-24 Polinucleotido aislado o recombinante, vector de expresion, celula huesped, metodo para preparar un polipeptido antigenico, metodo y equipo para ladeteccion de un polinucleotido, compuesto de union, metodo de empleo del compuesto de union, polipeptido antigenico aislado o substancialmente puro, ymet

Country Status (29)

Country Link
EP (3) EP2233574A1 (es)
JP (5) JP4316133B2 (es)
KR (1) KR100666835B1 (es)
CN (2) CN1271387A (es)
AR (2) AR017510A1 (es)
AT (1) ATE443142T1 (es)
AU (1) AU741046B2 (es)
BR (1) BR9811039A (es)
CA (1) CA2296272C (es)
CO (1) CO4810232A1 (es)
CZ (1) CZ300958B6 (es)
DE (1) DE69841161D1 (es)
DK (2) DK2100959T3 (es)
ES (2) ES2610483T3 (es)
HK (1) HK1024932A1 (es)
HU (1) HU230629B1 (es)
ID (1) ID28114A (es)
IL (3) IL134068A0 (es)
LT (1) LT2100959T (es)
MY (1) MY157028A (es)
NO (1) NO329329B1 (es)
NZ (1) NZ502391A (es)
PE (1) PE20000183A1 (es)
PL (1) PL197150B1 (es)
PT (2) PT2100959T (es)
SK (1) SK287198B6 (es)
TW (1) TWI237057B (es)
WO (1) WO1999005280A1 (es)
ZA (1) ZA986596B (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6060284A (en) 1997-07-25 2000-05-09 Schering Corporation DNA encoding interleukin-B30
DE69834938T2 (de) * 1997-10-23 2007-02-01 Nippon Institute For Biological Science, Oume Granulozyten-kolonie-stimulierender faktor aus der katze
WO1999040195A1 (en) * 1998-02-06 1999-08-12 Schering Corporation Mammalian receptor proteins; related reagents and methods
ATE474849T1 (de) 1998-04-14 2010-08-15 Chugai Pharmaceutical Co Ltd Neues cytokinartiges protein
AU2005202420B2 (en) * 1999-09-09 2008-08-07 Merck Sharp & Dohme Corp. Mammalian cytokines; related reagents and methods
US7090847B1 (en) 1999-09-09 2006-08-15 Schering Corporation Mammalian cytokines; related reagents and methods
DE60038304T3 (de) * 1999-09-09 2017-04-06 Merck Sharp & Dohme Corp. Interleukin-12 p40 und interleukin-b30. kombinationen davon. antikörper. verwendungen in pharmazeutische zusammensetzungen
EP1905832A3 (en) 1999-09-09 2009-09-09 Schering Corporation Mammalian interleukin-12 P40 and interleukin B30, combinations thereof, antibodies, uses in pharmaceutical compositions
DE60328823D1 (de) 2002-10-30 2009-09-24 Genentech Inc Hemmung von il-17 produktion
JP2007515939A (ja) 2003-05-09 2007-06-21 セントカー・インコーポレーテツド ＩＬ−２３ｐ４０特異的免疫グロブリン由来タンパク質、組成物、方法および用途
WO2005108425A1 (en) * 2004-05-10 2005-11-17 Cytos Biotechnology Ag Il-23 p19 antigen array and uses thereof
AR051444A1 (es) 2004-09-24 2007-01-17 Centocor Inc Proteinas derivadas de inmunoglobulina especifica de il-23p40, composiciones, epitopos, metodos y usos
JP2009501006A (ja) 2005-06-30 2009-01-15 セントカー・インコーポレーテツド 抗ｉｌ−２３抗体、組成物、方法および用途
PL1971366T3 (pl) 2005-12-29 2015-01-30 Janssen Biotech Inc Ludzkie przeciwciała skierowane przeciw IL-23, kompozycje, sposoby i zastosowanie
US7910703B2 (en) 2006-03-10 2011-03-22 Zymogenetics, Inc. Antagonists to IL-17A, IL-17F, and IL-23P19 and methods of use
WO2007147019A2 (en) 2006-06-13 2007-12-21 Zymogenetics, Inc. Il-17 and il-23 antagonists and methods of using the same
TWI426918B (zh) 2007-02-12 2014-02-21 Merck Sharp & Dohme Ｉｌ-２３拮抗劑於治療感染之用途
US8975382B2 (en) 2007-11-27 2015-03-10 Ablynx N.V. Amino acid sequences directed against HER2 and polypeptides comprising the same for the treatment of cancers and/or tumors
KR101508086B1 (ko) 2008-05-05 2015-04-07 노비뮨 에스 에이 항-ｉｌ-１７ａ／ｉｌ-１７ｆ 교차-반응성 항체 및 그의 사용 방법
RU2605318C2 (ru) 2009-05-05 2016-12-20 Новиммун С.А. Анти-il-17f антитела и способы их применения
JO3244B1 (ar) 2009-10-26 2018-03-08 Amgen Inc بروتينات ربط مستضادات il – 23 البشرية
PT2635601T (pt) 2010-11-04 2016-09-27 Boehringer Ingelheim Int Anticorpos anti-il-23
EP4039275A1 (en) 2012-05-03 2022-08-10 Boehringer Ingelheim International GmbH Anti-il-23p19 antibodies
KR20150128859A (ko) 2013-03-15 2015-11-18 암젠 인크 항-il23 항체를 사용하여 크론병을 치료하는 방법
WO2014149425A1 (en) 2013-03-15 2014-09-25 Amgen Inc. Methods for treating psoriasis using an anti-il-23 antibody
EP3172339A1 (en) 2014-07-24 2017-05-31 Boehringer Ingelheim International GmbH Biomarkers useful in the treatment of il-23a related diseases
BR112017004169A2 (pt) 2014-09-03 2017-12-05 Boehringer Ingelheim Int composto direcionado à il-23a e ao tnf-alfa e usos do mesmo
KR20180063127A (ko) 2015-09-17 2018-06-11 암젠 인크 Il23 경로 바이오마커를 사용한, il23-길항제에 대한 임상 반응의 예측
KR20180096633A (ko) 2015-12-22 2018-08-29 암젠 인크 Il23-길항제에 대한 임상적 반응의 예측인자로서의 ccl20
SG11202100185VA (en) 2018-07-13 2021-02-25 Astrazeneca Collaboration Ventures Llc Treating ulcerative colitis with brazikumab
CN113395979A (zh) 2018-11-20 2021-09-14 詹森生物科技公司 用抗il-23特异性抗体治疗银屑病的安全且有效的方法
AU2020279987A1 (en) 2019-05-23 2021-11-18 Janssen Biotech, Inc. Method of treating inflammatory bowel disease with a combination therapy of antibodies to IL-23 and TNF alpha
US11396541B2 (en) 2019-12-20 2022-07-26 Novarock Biotherapeutics, Ltd. Anti-interleukin-23 P19 antibodies and methods of use thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3645090A (en) 1969-06-19 1972-02-29 Citizen Watch Co Ltd Day-date quick-adjuster for calender timepiece
US3940475A (en) 1970-06-11 1976-02-24 Biological Developments, Inc. Radioimmune method of assaying quantitatively for a hapten
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
DE3382317D1 (de) 1982-03-15 1991-07-25 Schering Corp Hybride dns, damit hergestellte bindungszusammensetzung und verfahren dafuer.
US4659678A (en) 1982-09-29 1987-04-21 Serono Diagnostics Limited Immunoassay of antigens
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4859609A (en) 1986-04-30 1989-08-22 Genentech, Inc. Novel receptors for efficient determination of ligands and their antagonists or agonists
US5891680A (en) * 1995-02-08 1999-04-06 Whitehead Institute For Biomedical Research Bioactive fusion proteins comprising the p35 and p40 subunits of IL-12
ATE474849T1 (de) * 1998-04-14 2010-08-15 Chugai Pharmaceutical Co Ltd Neues cytokinartiges protein

Also Published As

Publication number Publication date
HK1024932A1 (en) 2000-10-27
AR017510A1 (es) 2001-09-12
KR100666835B1 (ko) 2007-01-11
PL338262A1 (en) 2000-10-09
DE69841161D1 (de) 2009-10-29
JP2001511347A (ja) 2001-08-14
NO20000343L (no) 2000-03-24
CA2296272A1 (en) 1999-02-04
PT2100959T (pt) 2017-01-09
HU230629B1 (hu) 2017-04-28
MY157028A (en) 2016-04-15
JP2005323610A (ja) 2005-11-24
LT2100959T (lt) 2017-01-10
CA2296272C (en) 2012-03-13
IL134068A (en) 2010-11-30
ATE443142T1 (de) 2009-10-15
ES2331762T3 (es) 2010-01-14
TWI237057B (en) 2005-08-01
NO20000343D0 (no) 2000-01-24
CN1271387A (zh) 2000-10-25
JP2010011863A (ja) 2010-01-21
KR20010022214A (ko) 2001-03-15
AU741046B2 (en) 2001-11-22
BR9811039A (pt) 2000-08-08
CZ2000263A3 (cs) 2000-06-14
NZ502391A (en) 2002-12-20
DK1002084T3 (da) 2010-01-04
JP2013034480A (ja) 2013-02-21
HUP0004019A2 (en) 2001-03-28
ES2610483T3 (es) 2017-04-27
CZ300958B6 (cs) 2009-09-23
EP2100959A3 (en) 2009-10-14
CN101851286A (zh) 2010-10-06
EP1002084B1 (en) 2009-09-16
EP2233574A1 (en) 2010-09-29
HUP0004019A3 (en) 2003-08-28
JP2015037405A (ja) 2015-02-26
EP1002084A1 (en) 2000-05-24
IL134068A0 (en) 2001-04-30
NO329329B1 (no) 2010-09-27
WO1999005280A1 (en) 1999-02-04
SK287198B6 (sk) 2010-03-08
PE20000183A1 (es) 2000-03-11
EP2100959B1 (en) 2016-12-07
JP4316133B2 (ja) 2009-08-19
SK912000A3 (en) 2000-09-12
ID28114A (id) 2001-05-03
CO4810232A1 (es) 1999-06-30
IL205765A0 (en) 2011-07-31
PT1002084E (pt) 2009-12-16
EP2100959A2 (en) 2009-09-16
PL197150B1 (pl) 2008-03-31
DK2100959T3 (en) 2017-01-30
IL205765A (en) 2015-07-30
ZA986596B (en) 1999-02-08
AU8589498A (en) 1999-02-16

Similar Documents

Publication Publication Date Title
AR086483A2 (es) Vector de expresion, celula huesped, metodo para preparar un polipeptido antigenico, metodo y equipo para la deteccion de un polinucleotido, anticuerpo, metodo de empleo del anticuerpo, y uso para la manufactura de un medicamento para modular la fisiologia o el desarrollo de una celula o celulas de cultivo de tejido
EP0150126A3 (en) The synthesis of protein with an identification peptide
AU7565991A (en) Variant cd44 surface proteins, dna sequences coding them, antibodies against these proteins and their use in diagnosis and therapy
DE69632536D1 (de) Impfstoffe für das respiratorische-synzytial-virus mit nuklein säuren
BR9713108A (pt) Colagenase recombinante do tipo i de clostridium histolytucum e o uso da mesma para o isolamento de células e de grupos de células
DE68929402T2 (de) Verfahren zur herstellung von wasserlöslichen polypeptiden
ES2046462T3 (es) Marcadores de activacion de celulas "t".
ATE80660T1 (de) Verfahren zur herstellung eines polypeptides.
ZA943464B (en) Vascular endothelial growth factor 2
GB8914020D0 (en) Synthetic peptides for use in thrombus detection
DE68922917D1 (de) KEX2-Endoprotease und Verfahren zu ihrer Herstellung.
IL69469A (en) Polypeptide having human h1-relaxin activity,double-stranded dna fragments coding therefor,vectors containing the dna fragments and methods for preparing the polypeptide,dna fragments and vectors
DK164940C (da) Polypeptid med human-gamma-interferonaktivitet, genteknologisk fremgangsmaade til fremstilling deraf, hybrid-plasmider indeholdende en dna-sekvens, der koder for peptidet, vaertsorganismer indeholdende hybridplasmiderne, samt laegemidler, som indeholder polypeptidet
AR013618A1 (es) Metodo y composiciones para la distribucion y expresion de acidos nucleicos de interferon
UA43350C2 (uk) Пептид, який викликає утворення антитіл, що проявляють нейтралізуючу активність відносно штамів та/або ізолятів віл-1 , та/або пригнічують злиття уражених віл-1 клітин, фармацевтичний засіб для утворення антитіл, спосіб отримання пептиду для утворення антитіл, спосіб отримання антитіл, антитіло iga, що проявляє віл-1 нейтралізуючу активність та/або пригнічує злиття уражених віл-1 клітин
EP0195680A3 (en) The synthesis of protein with an identification peptide
DE69836647D1 (de) Methode zur herstellung von (poly)peptiden unter verwendung von verkürzten varianten von sv40 'large' t antigen mit einem intakten n terminus
PT87239A (pt) Process for the preparation of peptides
AR004338A1 (es) Uso de una proteina derivada de una quimioquina para preparar un medicamento para tratar y prevenir la sepsis.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal